Brian Moran Cancer Institute to Open December 15, 2025

LISLE, IL / ACCESS Newswire / December 3, 2025 / Duly Health and Care, through one of its med­ical groups, DuPage Med­ical Group, Ltd., is proud to announce that the Bri­an Moran Can­cer Insti­tute (BMCI) will offi­cial­ly open on Decem­ber 15, 2025, expand­ing access to world-class can­cer care across Chicagoland. The Insti­tute will bring togeth­er advanced clin­i­cal care, research, and patient nav­i­ga­tion through­out a coor­di­nat­ed sys­tem designed to serve patients close to home.

The Insti­tute was first announced ear­li­er this year: https://www.dulyhealthandcare.com/news/duly-health-and-care-to-open-brian-moran-cancer-institute-expanding-access-to-advanced-patient-centered-cancer-care-in-the-chicago-suburbs

The Bri­an Moran Can­cer Insti­tute will align exper­tise in med­ical oncol­o­gy, radi­a­tion oncol­o­gy, sur­gi­cal sub­spe­cial­ties, and clin­i­cal research with­in one inte­grat­ed sys­tem. Through pre­ci­sion med­i­cine, expand­ed clin­i­cal tri­al access, and com­pre­hen­sive sup­port­ive care, BMCI will enhance the deliv­ery of can­cer treat­ment across the Chica­go suburbs.

Drs. Yarla­gad­da, Chichu­ra, and Bajaj to Join the Cen­ter for Breast Oncol­o­gy at the Bri­an Moran Can­cer Institute

As BMCI pre­pares to open, the Insti­tute is pleased to announce the expan­sion of its Cen­ter for Breast Oncol­o­gy, wel­com­ing three high­ly accom­plished physicians:

Dr. Sud­ha Yarla­gad­da, breast med­ical oncol­o­gist, join­ing BMCI from the Uni­ver­si­ty of Chica­go, where she served as an Assis­tant Pro­fes­sor of Med­i­cine and con­tributed exten­sive­ly to breast can­cer research and clin­i­cal trials.

Dr. Anna Chichu­ra, fel­low­ship-trained breast sur­geon, join­ing from the Uni­ver­si­ty of Illi­nois Chica­go, where she served as an Assis­tant Pro­fes­sor of Surgery with exper­tise in com­plex breast surgery and oncoplas­tic techniques.

Dr. Amishi Bajaj, radi­a­tion oncol­o­gist, join­ing BMCI from North­west­ern Med­i­cine in War­renville, bring­ing exper­tise in mul­ti­dis­ci­pli­nary care of breast can­cer and oth­er sol­id tumors.

“We are very excit­ed to wel­come Drs. Yarla­gad­da, Chichu­ra, and Bajaj to the Bri­an Moran Can­cer Insti­tute. Their exper­tise in breast oncol­o­gy will mean­ing­ful­ly expand our pro­gram and strength­en the care we pro­vide to our com­mu­ni­ty,” not­ed Bri­an Myre, MD, Direc­tor of the Bri­an Moran Can­cer Institute.

DuPage Med­ical Group, Ltd. dba Duly Health and Care of North­ern Illi­nois (“Duly”) is Duly’s Chicagoland med­ical group.

###

About the Bri­an Moran Can­cer Institute

Open­ing Decem­ber 15, 2025, the Bri­an Moran Can­cer Insti­tute at Duly Health and Care rep­re­sents a major invest­ment in bring­ing lead­ing-edge oncol­o­gy care to patients through­out the Chica­go sub­urbs and beyond. BMCI will pro­vide access to inno­v­a­tive can­cer treat­ments, numer­ous clin­i­cal tri­als, pre­ci­sion diag­nos­tics, and inte­grat­ed sup­port­ive ser­vices - all with­in one coor­di­nat­ed system.

About Duly Health and Care

The Duly Health and Care brand con­sists of some of the largest inde­pen­dent, mul­ti-spe­­­cial­­­ty, physi­­­cian-direc­t­ed med­ical groups in the nation, with more than 1,000 pri­ma­ry care and spe­cial­ty care providers and over 6,000 team mem­bers across more than 150 loca­tions. The Duly Health and Care brand includes three med­ical groups - DuPage Med­ical Group Ltd., Quin­cy Med­ical Group, and The South Bend Clin­ic LLC. Duly is deeply com­mit­ted to car­ing for patients in tra­di­tion­al and val­ue-based care arrange­ments, ensur­ing a focus on qual­i­ty, effi­cien­cy, and enhanced patient expe­ri­ences through­out the Midwest.

For more infor­ma­tion, vis­it duly​healt­hand​care​.com.

Media Contact
Amy Martin
amy@keybridge.biz
(202) 988-3222

SOURCE: Duly Health and Care

View the original press release on ACCESS Newswire